• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. HOMOGRAFT HEART VALVE, MORE THAN MINIMALLY MANIPULATED ALLOGRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. HOMOGRAFT HEART VALVE, MORE THAN MINIMALLY MANIPULATED ALLOGRAFT Back to Search Results
Device Problem Material Puncture/Hole (1504)
Patient Problems Exsanguination (1841); Low Blood Pressure/ Hypotension (1914); Abdominal Distention (2601)
Event Date 05/04/2021
Event Type  Death  
Event Description
Female who is postoperative day 4 following extensive repair of a para visceral mycotic aneurysm with distal descending thoracic to distal abdominal aortic cryopreserved graft through a left thoracotomy and left retroperitoneal approach as well as retrograde de branching of the renal arteries as well as the superior mesenteric artery. She actually tolerated the procedure very well and was making an excellent postoperative recovery. This evening she developed acute arterial hemorrhage emanating from the retroperitoneal drain as well as hypotension and abdominal distention. She was resuscitated in the icu and emergently brought down to the operating room. While resuscitation was ongoing the patient was placed in right lateral decubitus position on a beanbag and prepped and draped in a sterile manner from the level of the shoulder to the knees. Administration of preoperative antibiotic was confirmed, and a procedural pause was quickly observed. The left retroperitoneal incision was quickly opened, and a large volume of arterial blood and clots was evacuated. At this stage the patient became profoundly hypotensive and a fogarty hydragrip clamp was quickly placed on the abdominal segment of the thoracic aorta to abdominal aortic cryopreserved graft. It soon became evident that the bleeding was coming from a significant sized hole that had developed on the anterior wall of the distal aorta aortic cryopreserved graft. There was no hemorrhage from any of the suture lines or any of the other de branching graft. This was repaired with continuous pledgeted 5-0 prolene utilizing bovine pericardium as pledgets given the weak wall of the cryopreserved graft while intermittently cpr was being administered. Findings 1. Large volume arterial blood and clot evacuated from the retroperitoneal wound upon reopening. 2. Acute, profuse hemorrhage from 0. 75 cm hole anterior wall of distal aspect thoracic to distal abdominal aortic composite cryopreserved bypass graft. This case was substantially more difficult than usual because of significant effort and difficulty mobilizing and identifying anatomical structures due to altered surgical field secondary to previous surgery and tissue friability. This case was substantially more difficult than usual because of prolonged/ significant intra-operative hemorrhage. This case was substantially more difficult than usual because of serious medical condition(s) of the patient. Complications death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameHOMOGRAFT
Type of DeviceHEART VALVE, MORE THAN MINIMALLY MANIPULATED ALLOGRAFT
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd nw
kennesaw GA 30144
MDR Report Key11791606
MDR Text Key249520222
Report Number11791606
Device Sequence Number1
Product Code OHA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/07/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA05/06/2021
Event Location Hospital
Date Report to Manufacturer05/07/2021
Was Device Evaluated by Manufacturer? No Answer Provided
Is the Device Single Use? No Answer Provided
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unkown

Patient Treatment Data
Date Received: 05/07/2021 Patient Sequence Number: 1
-
-